Biomimetic Folate-Targeted Lanthanide-Doped Gold Nanoparticles as Imaging Probes for Dual-Mode Spectral Photon-Counting CT and T2-Weighted Magnetic Resonance Imaging
Source abstract
Abstract
Multifunctional nanoparticles (MNPs) have enormous potential for multimodal cancer imaging and effective targeted delivery of cancer. Herein, folate-targeted Au/lanthanide (FAB@Au/Ln-DTPA, Ln = Dy, Ho, Er) nanoparticles (NPs) were developed as dual-mode contrast agents for spectral photon-counting computed tomography (SPCCT) and magnetic resonance imaging (MRI). The NPs were synthesized using folic acid (FA) as targeting ligands and BSA as a bio-template. TEM imaging confirmed that the NPs are spherical with a narrow size distribution (12.2–13.6 nm). Biocompatibility assays conducted with MDA-MB-231 and A549 cell lines, and hemolysis with human red blood cells, demonstrated low cytotoxicity and hemocompatibility (IC50 > 300 μg/mL), indicating excellent biocompatibility. SPCCT imaging revealed a dual K-edge X-ray contrast arising from the combination of Au and Ln elements. MRI results showed relaxivity values of 36.65, 32.01, and 31.67 mM −1 s −1 for FAB@Au/Dy-DTPA, FAB@Au/Ho-DTPA, and MDAMB-23-DTPA, respectively, indicating T 2 -weighted contrast enhancement. Cellular uptake analysis revealed greater internalization in MDA-MB-231 cells than in A549 cells, suggesting folate receptor-mediated uptake. In general, FAB@Au/Ln-DTPA nanoparticles demonstrated high potential as a biocompatible dual-modality imaging agent for spectral photon-counting CT and magnetic resonance imaging, with targeting capability for imaging cancer cells overexpressing folate receptors. These nanoparticles can serve as a delivery vehicle for future imaging-guided therapy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Lanthanide and Transition Metal Complexes · Nanoplatforms for cancer theranostics · Advanced X-ray and CT Imaging
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (81)
Show source-provided references
1. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2. Nowcasting and forecasting global aging and cancer burden: analysis of data from the GLOBOCAN and global burden of disease study
3. Sera · 2021 · 167
4. Klein · 2024 · 1
5. Photon-counting CT systems: a technical review of current clinical possibilities, Diagn
6. Spectral photon-counting computed tomography: a review on technical principles and clinical applications10.3390/jimaging8040112 ↗
7. Spectral photon-counting computed tomography: technical principles and applications in the assessment of cardiovascular diseases10.3390/jcm13082359 ↗
8. Recent advances in magnetic resonance imaging for the diagnosis of liver cancer: a comprehensive review10.3390/diagnostics15162016 ↗
9. Gadolinium contrast agents- challenges and opportunities of a multidisciplinary approach: literature review10.1016/j.ejro.2023.100503 ↗
10. Gadolinium deposition disease: a new risk management threat10.1016/j.jacr.2019.11.009 ↗
11. Ten years of gadolinium retention and deposition: ESMRMB-GREC looks backward and forward10.1007/s00330-023-10281-3 ↗
12. Effects of iron oxide nanoparticles as T2-MRI contrast agents on reproductive system in Male mice10.1186/s12951-022-01291-2 ↗
13. Monodispersed ultrathin GdF3 nanowires: oriented attachment, luminescence, and relaxivity for MRI contrast agents10.1039/c2jm34987f ↗
14. HoF3 and DyF3 nanoparticles as contrast agents for high-field magnetic resonance imaging10.1002/ppsc.201700116 ↗
15. Terbium-doped manganese carbonate nanoparticles with intrinsic photoluminescence and magnetic resonance imaging capacity10.1016/j.jcis.2016.09.010 ↗
16. NMR transversal relaxivity of suspensions of lanthanide oxide nanoparticles10.1021/jp072288l ↗
17. Molecular imaging for biomimetic nanomedicine in cancer therapy: current insights and challenges10.1021/acsami.4c19720 ↗
18. Vision 20/20: simultaneous CT-MRI — next chapter of multimodality imaging10.1118/1.4929559 ↗
19. Fusion of CT and MRI modalities for brain tumors classification using enhanced machine vision framework10.1016/j.asej.2025.103669 ↗
20. CT and MRI image fusion via multimodal feature interaction network10.1007/s13721-024-00449-2 ↗
21. Multi-Modal image fusion for medical diagnosis: combining MRI and CT using deep generative models10.18535/cmhrj.v5i03.486 ↗
22. Jiang · 2023 · vol. 13
23. Harnessing nanotechnology for cancer treatment10.3389/fbioe.2024.1514890 ↗
24. Nanotechnology: a promising approach for cancer diagnosis, therapeutics and theragnosis10.2147/IJN.S378074 ↗
25. Comparison of gold nanoparticles and iodinated contrast media in radiation dose reduction and contrast enhancement in computed tomography, Iran
26. Folic acid-modified diatrizoic acid-linked dendrimer-entrapped gold nanoparticles enable targeted CT imaging of human cervical cancer10.7150/jca.19786 ↗
27. Novel contrast agents for Spectral photon counting computed tomography (SPCCT)
28. Biodegradable poly(amino acid)–bismuth nanotheranostic agents for CT/MR imaging and photothermal–chemodynamic synergistic therapy
29. Hariyadi, enhancing biomedical imaging: the role of nanoparticle-based contrast agents10.1007/s10544-024-00725-y ↗
30. Dual-imaging nanoparticles based on surface-modified magnetic nanoparticles and biodegradable photoluminescent polymers10.3389/fbioe.2025.1558817 ↗
31. Magnetic nanoparticle-polymer nanocomposites for enhanced magnetic resonance imaging (MRI) contrast agents: a review10.1134/S106378262460222X ↗
32. Novel advancements in nanomaterials-based contrast agents across multimodal imaging and theranostic applications10.1039/D5NA00596E ↗
33. Development and characterization of new contrast agents for photon-counting CT10.1016/j.ejrad.2025.112643 ↗
34. Color K-edge angiography with a dedicated gadolinium-based contrast agent for spectral photon-counting computed tomography10.1016/j.diii.2025.07.001 ↗
35. Energy-sensitive photon counting detector-based X-ray computed tomography10.1007/s12194-017-0390-9 ↗
36. LHRH conjugated gold nanoparticles assisted efficient ovarian cancer targeting evaluated via spectral photon-counting CT imaging: a proof-of-concept research10.1039/D2TB02416K ↗
37. Surface modification effect on contrast agent efficiency for X-ray based spectral photon-counting scanner/luminescence imaging: from fundamental study to in vivo proof of concept10.1039/D3NR03710J ↗
38. Ytterbium nanoparticle contrast agents for conventional and spectral photon-counting CT and their applications for hydrogel imaging10.1021/acsami.2c12354 ↗
39. Nanoparticulated bimodal contrast agent for ultra-high-field magnetic resonance imaging and spectral X-ray computed tomography10.1021/acs.inorgchem.4c01114 ↗
40. Bicolor K-edge spectral photon-counting CT imaging for the diagnosis of thoracic endoleaks: a dynamic phantom study10.1016/j.diii.2022.12.003 ↗
41. Element-specific spectral imaging of multiple contrast agents: a phantom study10.1088/1748-0221/13/02/T02001 ↗
42. Multifunctional Poly(Acrylic Acid)-Coated EuBiGd2O3 nanocomposite as an effective contrast agent in spectral photon counting CT, MRI, and fluorescence imaging10.2147/IJN.S506187 ↗
43. Gold nanoparticles spectral CT imaging and limit of detectability in a new materials contrast-detail phantom10.1016/j.ejmp.2024.103326 ↗
44. Assessment of material identification errors, image quality, and radiation doses using small animal spectral photon-counting CT10.1109/TRPMS.2020.3003260 ↗
45. Dual-contrast biphasic liver imaging with iodine and gadolinium using photon-counting detector computed tomography: an exploratory animal study10.1097/RLI.0000000000000815 ↗
46. Dhawan · 2023
47. Co-Delivery of methotrexate and nanohydroxyapatite with polyethylene glycol polymers for chemotherapy of osteosarcoma10.3390/mi14040757 ↗
48. Near-infrared-driven upconversion nanoparticles with photocatalysts through water-splitting towards cancer treatment10.1039/D3TB01066J ↗
49. Different targeting ligands-mediated drug delivery systems for tumor therapy10.3390/pharmaceutics16020248 ↗
50. Advances in targeting the folate receptor in the treatment/imaging of cancers10.1039/C7SC04004K ↗
51. Folate receptor targeted delivery of paclitaxel to breast cancer cells via folic acid conjugated graphene oxide grafted methyl acrylate nanocarrier10.1016/j.biopha.2018.12.008 ↗
52. Folate receptor-α targeted delivery of berberine via folate-functionalized bovine serum albumin nanocarriers to enhance intracellular internalization and suppress 3D spheroid formation as a pioneering therapeutic modality for glioblastoma10.1039/D5TB01715G ↗
53. Folic acid, folate conjugates and folate receptors: novel applications in imaging of cancer and inflammation-related conditions10.2147/CMAR.S549662 ↗
54. Serum albumin nanoparticles: ligand functionalization for enhanced targeted therapeutics in precision medicine10.1016/j.medidd.2025.100218 ↗
55. The uniqueness of Albumin as a carrier in nanodrug delivery10.1021/acs.molpharmaceut.1c00046 ↗
56. Hemato-biochemical profile of Turkey birds selected from Sherpur district of Bangladesh
57. pH-induced conformational isomerization of bovine serum albumin studied by extrinsic and intrinsic protein fluorescence10.1007/s10895-010-0781-3 ↗
58. MARS spectral molecular imaging of lamb tissue: data collection and image analysis10.1088/1748-0221/9/02/P02005 ↗
59. Assessment of material identification and quantification in the presence of metals using spectral photon counting CT10.1371/journal.pone.0308658 ↗
60. Development and evaluation of a single domain antibody targeting folate receptor alpha for radioligand therapy10.1186/s12951-024-03008-z ↗
61. Evaluation of folate receptor-alpha and other surface markers as potential targets for radionuclide therapy of ovarian cancer10.1186/s13550-025-01345-0 ↗
62. Chemistry of MRI contrast agents: current challenges and new frontiers10.1021/acs.chemrev.8b00363 ↗
63. Magnetic nanoparticle-polyelectrolyte interaction: a layered approach for biomedical applications10.1166/jnn.2008.AN02 ↗
64. Size-dependent glioblastoma targeting by polymeric nanoruler with prolonged blood circulation10.1021/acs.bioconjchem.4c00235 ↗
65. Clearance of nanoparticles from blood: effects of hydrodynamic size and surface coatings10.1039/D3EN00812F ↗
66. Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles10.1016/j.jconrel.2013.09.013 ↗
67. Preparation and characterization of BSA as a model protein loaded chitosan nanoparticles for the development of protein-/peptide-based drug delivery system
68. Systematic FTIR spectroscopy study of the secondary structure changes in human serum albumin under various denaturation conditions10.3390/biom9080359 ↗
69. Folic-acid-conjugated thermoresponsive polymeric particles for targeted delivery of 5-Fluorouracil to CRC cells10.3390/ijms24021364 ↗
70. Synergistic effect of folate-conjugated polymers and 5-fluorouracil in the treatment of colon cancer10.1186/s12645-021-00104-9 ↗
71. Folate-functionalized nanoparticles for controlled 5-Fluorouracil delivery10.1016/j.jcis.2010.10.054 ↗
72. Folic acid-conjugated silica-modified gold nanorods for X-ray/CT imaging-guided dual-mode radiation and photo-thermal therapy10.1016/j.biomaterials.2011.08.086 ↗
73. Engineered BSA nanoparticles: synthesis, drug loading, and advanced characterization10.1007/978-1-0716-4434-8 ↗
74. In vitro hemolysis: guidance for the pharmaceutical scientist10.1002/jps.20627 ↗
75. pH-sensitive curcumin conjugated micelles for tumor triggered drug delivery10.1080/09205063.2020.1833815 ↗
76. K-Edge imaging in spectral photon-counting computed tomography: a benchtop system study
77. High atomic number nanoparticles to enhance spectral CT imaging aspects10.1039/D3MA00231D ↗
78. Delft university of technology recent advances in lanthanide-based nanoparticle contrast agents for magnetic resonance imaging synthesis , characterization , and applications OpenNano recent advances in lanthanide-based nanoparticle contrast agents for ma
79. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths10.1097/01.rli.0000184756.66360.d3 ↗
80. Hydrophilic biocompatible Poly(Acrylic acid-co-maleic acid) polymer as a surface-coating ligand of ultrasmall Gd(2)O(3) nanoparticles to obtain a high r(1) value and T(1) MR images10.3390/diagnostics11010002 ↗
81. Polyaspartic acid-coated paramagnetic gadolinium oxide nanoparticles as a dual-modal T1 and T2 magnetic resonance imaging contrast agent10.3390/app11178222 ↗